D68.312

Clinical Causes: Presence of antiphospholipid antibodies, such as lupus anticoagulant (LAC), which interfere with normal blood clotting. Autoimmune diseases, primarily systemic lupus erythematosus (SLE), which can produce inhibitors affecting blood coagulation. Other autoimmune conditions that trigger the immune system to produce antibodies damaging blood components. Certain medications or infections that may stimulate the production of antiphospholipid antibodies.

Key Symptoms: Unusual bleeding, such as nosebleeds, bleeding gums, or heavy menstrual periods. Bleeding or bruising easily from minor injuries. Signs of blood clots, such as swelling, pain, or redness in limbs. Symptoms of systemic lupus erythematosus, including fatigue, joint pain, skin rashes, and fever. In severe cases, internal bleeding or bleeding into joints or tissues.

Diagnosis Path: Diagnosing this disorder involves a combination of blood tests to detect antiphospholipid antibodies, such as lupus anticoagulant, anticardiolipin antibodies, and anti-β2 glycoprotein I antibodies. Healthcare providers also assess clinical history and symptoms to differentiate between bleeding tendencies and clotting risks. Additional tests may include complete blood count (CBC), coagulation studies, and screening for autoimmune markers. Imaging studies could be used if internal bleeding or blood clots are suspected.

Treatment Protocols: Using anticoagulant medications to prevent blood clots in patients at risk, under careful medical supervision. Immunosuppressive therapies in cases linked to autoimmune diseases like SLE. Medications to control bleeding episodes if present, such as clotting factor concentrates or supportive care. Monitoring blood counts and autoimmune activity regularly to adjust treatment plans. Lifestyle adjustments and avoiding medications or factors that could exacerbate bleeding risks.